Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Dela J Public Health ; 7(1): 32-36, 2021 Jan.
Article in English | MEDLINE | ID: mdl-34467177

ABSTRACT

Consumers are increasingly confused by the numerous meat labels confronting them in the meat case. Most meat labels do not provide actionable information and many labels only add to consumer confusion. While many consumers are willing to pay a premium for products with specific attributes, the trade-offs and unintended consequences associated with various animal raising programs are not transparent and often poorly understood. Adding to this confusion is a tendency toward the use of "absence labels" on meat products that can create a negative perception of unlabeled conventional products that may or may not include the attribute in question. Communicating with consumers about the complex issue of antimicrobial resistance (AMR) is challenging. A more balanced approach to raising food animals is a new consumer choice label program based on principles of One Health that provides transparent information to consumers with mandated antibiotic stewardship practices to reduce risk of AMR originating from food animals. This holistic program strives to provide optimal health outcomes for animals, people, and the environment and avoid the negative consequences sometimes associated with more narrowly focused programs.

2.
Ann N Y Acad Sci ; 1441(1): 31-39, 2019 04.
Article in English | MEDLINE | ID: mdl-30924542

ABSTRACT

To reduce the use of antibiotics in animal agriculture, a number of effective or commercially viable alternatives have been implemented by food animal producers or are under development. Perhaps the most well-established strategies are flock and herd management practices to mitigate disease introduction and spread, and, subsequently, reduce the need for antibiotic use. While vaccines in food animal production have been used to prevent both bacterial and viral diseases, but historically, most vaccines have targeted viral diseases. Though vaccines against viral diseases can help reduce the need for antibiotic use by controlling the spread of secondary bacterial infections, more recent vaccines under development specifically target bacteria. New developments in selecting and potentially tailoring bacteriophages provide a promising avenue for controlling pathogenic bacteria without the need for traditional small-molecule antibiotics. In this article we discuss these established and emerging strategies, which are anticipated to reduce the reliance on antibiotics in food animal production and should reduce the prevalence and transmission to humans of antimicrobial resistant bacteria from these systems.


Subject(s)
Agriculture , Animals, Domestic , Phage Therapy/methods , Animals , Anti-Bacterial Agents/administration & dosage , Bacteriophages , Communicable Disease Control/methods , Drug Resistance, Microbial , Vaccines/administration & dosage
3.
Ann N Y Acad Sci ; 1441(1): 40-49, 2019 04.
Article in English | MEDLINE | ID: mdl-30924543

ABSTRACT

Consumers are increasingly interested in the attributes of the food they consume. This includes what is in the food and how it was raised; and at least some consumers are willing to pay a premium for products with specific attributes. However, the current plethora of labels on the market does not adequately address this issue; rather than providing actionable information, most labels add to the consumer confusion. In addition, there is a tendency toward "absence labels" that can contribute to a negative consumer perception of conventional products that may or may not include the attribute in question. Communication with consumers about the complex and highly technical issue of antimicrobial resistance (AMR) is challenging, and experiences from communication efforts about food safety-related issues demonstrate exactly how challenging this is to communicate clearly. General lessons learned from the science of risk communication can help guide efforts to communicate about the challenging issue of AMR. There are efforts underway to chart out a new approach. A new labeled animal production certification program is under development to provide choice for consumers, while reducing consumer confusion, which mandates antibiotic stewardship practices.


Subject(s)
Bacterial Infections/transmission , Consumer Behavior , Drug Resistance, Bacterial , Food Microbiology , Food Safety , Animals , Anti-Bacterial Agents/administration & dosage , Bacterial Infections/microbiology , Food Labeling , Risk Factors
4.
Res Vet Sci ; 93(2): 721-8, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22301016

ABSTRACT

This study investigated the effects of various coccidiosis control programs in combination with antibiotic growth promoters (AGPs) on growth performance and host immune responses in broiler chickens. The coccidiosis programs that were investigated included in ovo coccidiosis vaccination (CVAC) with Inovocox or in-feed medication with diclazuril as Clinacox (CLIN) or salinomycin (SAL). The AGPs were virginiamycin or bacitracin methylene disalicylate plus roxarsone. As a negative control, chickens were non-vaccinated and fed with non-supplemented diets (NONE). All animals were exposed to used litter from a commercial broiler farm with confirmed contamination by Eimeria parasites to simulate in-field exposure to avian coccidiosis. Broiler body weights in the CVAC group were greater at 14 and 32 days of age, but not at day 42, compared with the NONE, CLIN, and SAL groups. At day 14, the SAL group showed decreased body weight and reduced ConA-stimulated spleen cell proliferation compared with the CLIN and SAL groups. In contrast, at days 34 and 43, splenocyte proliferation was greater in the CVAC and CLIN groups compared with the NONE and SAL groups. Lymphocyte subpopulations and cytokine mRNA expression levels in the intestine and spleen were also altered by the denoted treatments. Collectively, these results suggest that in ovo coccidiosis vaccination or coccidiostat drug medication programs in combination with AGPs influences chicken growth and immune status in an Eimeria-contaminated environment.


Subject(s)
Anti-Bacterial Agents/pharmacology , Chickens/growth & development , Coccidiosis/veterinary , Nitriles/pharmacology , Protozoan Vaccines/immunology , Pyrans/pharmacology , Triazines/pharmacology , Animal Feed/analysis , Animals , Chick Embryo , Chickens/immunology , Coccidiosis/prevention & control , Coccidiostats/pharmacology , Cytokines/genetics , Cytokines/metabolism , Eimeria , Gene Expression Regulation , Male , Poultry Diseases/drug therapy , Poultry Diseases/prevention & control , RNA, Messenger/genetics , RNA, Messenger/metabolism , Spleen/cytology
5.
Res Vet Sci ; 93(1): 177-82, 2012 Aug.
Article in English | MEDLINE | ID: mdl-21641010

ABSTRACT

The present study reports the effects of various field anticoccidial programs on the distribution of Eimeria spp. in poultry litter and serum antibody titers against coccidia in broiler chickens raised on the used litters. The programs included in ovo vaccination and various medications with either chemicals, ionophores, or both. In general, serum samples from these chickens showed anticoccidial antibody titers when tested at days 7 and 14 post hatch with the peak response at day 43. Serum anticoccidial titers were highest in birds fed a non-medicated diet compared with those vaccinated or fed medicated diets. Total number of Eimeria oocysts and the composition of Eimeria spp. present in the litter samples from different treatment groups varied depending on the type of anticoccidial program. Oocyst counts in general ranged from 3.7×10(3) to 7.0×10(4) per g of litter. Importantly, both morphological and molecular typing studies revealed four major predominant Eimeria spp., E. acervulina, E. maxima, E. praecox, and E. tenella in the litter samples. Collectively, these results indicate that the field anticoccidial programs influenced the type and abundance of Eimeria spp. present in the litter samples and also modulated host immune response to Eimeria.


Subject(s)
Antibodies, Protozoan/blood , Coccidiosis/veterinary , Coccidiostats/pharmacology , Eimeria/immunology , Ovum/parasitology , Poultry Diseases/immunology , Vaccination/veterinary , Animals , Antibodies, Protozoan/immunology , Chickens/immunology , Chickens/parasitology , Coccidiosis/immunology , Coccidiosis/prevention & control , Eimeria tenella/immunology , Housing, Animal , Ovum/drug effects , Ovum/immunology , Parasite Egg Count/veterinary , Poultry Diseases/prevention & control , Vaccination/methods
6.
Avian Dis ; 55(4): 539-44, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22312971

ABSTRACT

This study was carried out to investigate the effects of exposure of growing broiler chickens of commercial origin to used poultry litter on intestinal and systemic immune responses. The litter types evaluated were fresh wood shavings or used litter obtained from commercial poultry farms with or without a history of gangrenous dermatitis (GD). Immune parameters measured were serum nitric oxide (NO) levels, serum antibody titers against Eimeria or Clostridium perfringens, mitogen-induced spleen cell proliferation, and intestinal intraepithelial lymphocyte or splenic lymphocyte subpopulations. At 43 days posthatch, birds raised on used litter from a GD farm had higher serum NO levels and greater Eimeria or C. perfringens antibody levels compared with chickens raised on fresh litter or used, non-GD litter. Birds raised on non-GD and GD used litter had greater spleen cell mitogenic responses compared with chickens raised on fresh litter. Finally, spleen and intestinal lymphocyte subpopulations were increased or decreased depending on the litter type and the surface marker analyzed. Although it is likely that the presence of Eimeria oocysts and endemic viruses varies qualitatively and quantitatively between flocks and, by extension, varies between different used litter types, we believe that these data provide evidence that exposure of growing chicks to used poultry litter stimulates humoral and cell-mediated immune responses, presumably due to contact with contaminating enteric pathogens.


Subject(s)
Chickens/immunology , Floors and Floorcoverings , Aging , Animals , Animals, Newborn , Antibodies, Protozoan/blood , Cell Proliferation , Clostridium perfringens/immunology , Eimeria/immunology , Housing, Animal , Intestines/growth & development , Intestines/immunology , Lymphocytes/physiology , Male , Mitogens/pharmacology , Nitric Oxide/metabolism , Spleen/cytology , Spleen/drug effects , Weight Gain
7.
Avian Pathol ; 39(4): 247-53, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20706880

ABSTRACT

The present report describes an outbreak of gangrenous dermatitis (GD) infection in a commercial poultry farm in Delaware involving 34-day-old broiler chickens. In addition to obvious clinical signs, some GD-affected broilers also showed severe fibrino-necrotic enteritis and large numbers of Gram-positive rods in the necrotic tissue. Histopathological findings included haemorrhage, degeneration and necrosis of parenchymatous cells, especially of skin, muscle, and intestine. Immunofluorescence staining revealed Clostridium-like bacilli in the skin and the intestine. Both Clostridium perfringens and Clostridium septicum genomic sequences were identified by polymerase chain reaction in bacterial cultures isolated from the skin, muscle, and intestine, and in the frozen tissues from the GD-affected birds. Serological analysis demonstrated that both affected and clinically healthy birds from the same house had high serum antibody titres against C. perfringens, C. septicum, Eimeria, chick anaemia virus, and infectious bursal disease virus. These results are discussed in the context of the relationship between the different Clostridium spp. and the pathogenesis of GD.


Subject(s)
Chickens , Clostridium/genetics , Dermatitis/veterinary , Disease Outbreaks/veterinary , Gangrene/veterinary , Poultry Diseases/epidemiology , Poultry Diseases/microbiology , Poultry Diseases/pathology , Animals , Antibodies, Bacterial/blood , DNA Primers/genetics , Delaware/epidemiology , Dermatitis/epidemiology , Dermatitis/microbiology , Dermatitis/pathology , Fluorescent Antibody Technique, Indirect , Gangrene/epidemiology , Gangrene/pathology , Polymerase Chain Reaction
8.
Avian Pathol ; 39(4): 255-64, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20706881

ABSTRACT

Gangrenous dermatitis (GD) is an emerging disease of increasing economic importance in poultry resulting from infection by Clostridium septicum and Clostridium perfringens type A. Lack of a reproducible disease model has been a major obstacle in understanding the immunopathology of GD. To gain better understanding of host-pathogen interactions in GD infection, we evaluated various immune parameters in two groups of birds from a recent commercial outbreak of GD, the first showing typical disease signs and pathological lesions (GD-like birds) and the second lacking clinical signs (GD-free birds). Our results revealed that GD-like birds showed: reduced T-cell and B-cell mitogen-stimulated lymphoproliferation; higher levels of serum nitric oxide and alpha-1-acid glycoprotein; greater numbers of K55(+), K1(+), CD8(+), and MHC class II(+) intradermal lymphocytes, and increased K55(+), K1(+), CD8(+), TCR1(+), TCR2(+), Bu1(+), and MHC class II(+) intestinal intraepithelial lymphocytes; and increased levels of mRNAs encoding proinflammatory cytokines and chemokines in skin compared with GD-free chickens. These results provide the first evidence of altered systemic and local (skin and intestine) immune responses in GD pathogenesis in chickens.


Subject(s)
Chickens , Clostridium/pathogenicity , Dermatitis/veterinary , Gangrene/veterinary , Lymphocytes/immunology , Poultry Diseases/immunology , Poultry Diseases/microbiology , Poultry Diseases/pathology , Animals , Antibodies, Monoclonal , Cell Proliferation , Chemokines/immunology , Clostridium/genetics , Cytokines/immunology , DNA Primers/genetics , Delaware , Dermatitis/immunology , Dermatitis/microbiology , Dermatitis/pathology , Gangrene/immunology , Gangrene/pathology , Host-Pathogen Interactions , Immunohistochemistry , Nitric Oxide/blood , Orosomucoid/immunology , Reverse Transcriptase Polymerase Chain Reaction
SELECTION OF CITATIONS
SEARCH DETAIL
...